Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo

MLA

Gabriela Reyes-Castellanos, et al. “Combining the Antianginal Drug Perhexiline with Chemotherapy Induces Complete Pancreatic Cancer Regression in Vivo.” IScience, vol. 26, no. 6, June 2023. EBSCOhost, https://doi.org/10.1016/j.isci.2023.106899.

APA

Gabriela Reyes-Castellanos, Nadine Abdel Hadi, Scarlett Gallardo-Arriaga, Rawand Masoud, Julie Garcia, Sophie Lac, Abdessamad El Kaoutari, Tristan Gicquel, Mélanie Planque, Sarah-Maria Fendt, Laetitia Karine Linares, Odile Gayet, Fabienne Guillaumond, Nelson Dusetti, Juan Iovanna, & Alice Carrier. (2023). Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo. IScience, 26(6). https://doi.org/10.1016/j.isci.2023.106899

Chicago

Gabriela Reyes-Castellanos, Nadine Abdel Hadi, Scarlett Gallardo-Arriaga, Rawand Masoud, Julie Garcia, Sophie Lac, Abdessamad El Kaoutari, et al. 2023. “Combining the Antianginal Drug Perhexiline with Chemotherapy Induces Complete Pancreatic Cancer Regression in Vivo.” IScience 26 (6). doi:10.1016/j.isci.2023.106899.